Page 121 - HPP ANTIMICROBIAL GUIDELINE 2018
P. 121
Suggested Treatment
Infection/ Condition Comments
Preferred Alternative
CMV Retinitis Ganciclovir 5mg/kg IV q12h for ** Valganciclovir: 900mg PO q12h Maintenance may need to continue
2-3 weeks for 3 weeks ( induction) followed by until CD4 count is >150 cells/mm3 for
900mg PO q24h (maintenance) 3 consecutive months
PLUS
Intravitreal ganciclovir 2mg/0.1ml Intravitreal **Foscarnet 2.4mg/0.1ml
biweekly (1-2weekly) Intravitreal therapy is indicated in
zone 1 and 2 lesions.
Ganciclovir implant: 4.5gm an option
for prolonged usage of intravitreal
ganciclovir
**Requires DG approval
Ocular Syphilis Ocular Syphilis ( syphilitic uveitis) Referral to Dermatologist/ID
should be treated as Neurosyphilis Physician
Refer to Sexually Transmitted
Infections Section
HPP AMG Ocular Infections 55
